Monday, 15 May 2017

Therapeutic and preventive implications of moonshot in hereditary cancer syndromes

President Obama’s proposed fiscal year 2017 budget includes $1 billion for eliminating cancer. This initiative has led to the belief that concentrating on treatment is a limited approach to the overall reduction of cancer mortality, considering the success of cancer research in prevention. However, a powerful method for cancer prevention and survival has been the discipline of hereditary cancer syndromes. This article discusses the significance of investing billions of dollars in genomic sequencing and the implications of finding a hereditary mutation in patients with metastatic cancer using next-generation sequencing (NGS).

Read more here.

No comments:

Post a Comment